Slide background

VetiVax™ Autologous Cancer Immunotherapy


Giving The Body A Fighting Chance

Harnessing the Immune System to Fight Cancer


Immunotherapies are gaining traction in both human and veterinary medicine as a sole, or adjunct, treatment to chemotherapy and/or radiation. With over 10 years of supporting research, VetiVax™ is a whole cell tissue immunotherapy that allows for a variety of tumor antigens to be presented to the immune system. By using a patient’s own tumor cells to create a personalized cancer immunotherapy, VetiVax™ presents an abundant choice of antigens that educates the patient’s immune system to recognize the cancer as foreign, and thus increasing the likelihood of a successful response.

Request More Information


Learn much more about VetiVax™ and how it can help your patients!


Download VetiVax™ Informational Brochure


What Are Surgeons Saying About VetiVax™?



Slide background

VetiVax™ can work for solid tumors,
including the following:

  • Melanoma
  • Squamous Cell Carcinoma
  • Fibrosarcoma
  • Soft Tissue Sarcoma
  • Hemangiosarcoma
  • Hepatocellular Carcinoma
  • Nasal Carcinoma
  • Adenocarcinoma
  • Mast Cell Tumors
  • Basal Cell Carcinoma
  • Transitional Cell

Using a surgically excised portion of
the tumor, our laboratory creates a multi-dose VetiVax™
treatment that is administered subcutaneously over three to four weeks.

The Process Is Easy

*Approximately 5 grams of tumor material is needed for processing

Get Your Free Tumor Collection Kit


Drop us a line, and one of our specialists will be happy to answer any questions


Request More Information
    Download VetiVax™      Informational Brochure

VetiVax™ is an experimental treatment regulated under USDA 9 CFR 103.3. For use under supervision/prescription of a licensed veterinarian. Efficacy and safety have not been established.